Kane Biotech Inc. (CVE:KNE – Get Free Report) reached a new 52-week low on Monday . The company traded as low as C$0.03 and last traded at C$0.03, with a volume of 5014 shares. The stock had previously closed at C$0.03.
Kane Biotech Price Performance
The stock has a market cap of C$4.99 million, a PE ratio of -0.33 and a beta of 0.03. The business has a 50-day moving average price of C$0.04 and a 200-day moving average price of C$0.05. The company has a current ratio of 0.80, a quick ratio of 0.39 and a debt-to-equity ratio of -331.42.
About Kane Biotech
Kane Biotech Inc, a biotechnology company, engages in the research, development, and commercialization of technologies and products that prevent and remove microbial biofilms in Canada and internationally. The company develops its products using coactiv+ technology, an antimicrobial wound gel platform; and DispersinB technology, a naturally occurring enzyme that cleaves the bacterial surface polysaccharide poly-b-1, 6-N-acetylglucosamine for treating wounds and otic infections.
Further Reading
- Five stocks we like better than Kane Biotech
- Russell 2000 Index, How Investors Use it For Profitable Trading
- $134M in Insider Moves: What It Might Mean for KMI, ISRG and QS
- Mastering Discipline: Overcoming Emotional Challenges In Trading
- 3 Stocks Flashing Buy Signals With $8.5 Billion in Buybacks
- What to Know About Investing in Penny Stocks
- Freshpet Insiders Called the Bottom: Now It’s Time to Buy
Receive News & Ratings for Kane Biotech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kane Biotech and related companies with MarketBeat.com's FREE daily email newsletter.
